A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Ravulizumab in Complement-Inhibitor-Naive Adult Patients with Generalized Myasthenia Gravis
Clinical Trial Grant
Administered By
Neurology, Neuromuscular Disease
Awarded By
Alexion Pharmaceuticals, Inc.
Start Date
June 18, 2019
End Date
December 31, 2023
Administered By
Neurology, Neuromuscular Disease
Awarded By
Alexion Pharmaceuticals, Inc.
Start Date
June 18, 2019
End Date
December 31, 2023